This article discusses the schedule classification and effects of MDMA. The potential damage, therapeutic effects and reclassification of MDMA are examined in a new perspective that challenges past notions which lead to it's scheduling as a class one drug.
Cromer, Alison, "Molly: The Not So Convincing Truth of MDMA" (2013). Sound Neuroscience Temporary. Paper 13.